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Introduction 
In a previous study we showed that patients using automated drug 
dispensing had more drug changes after a medication review compared to 
patients in a waiting-list group (2.2 vs.1.0 per patient)[1]. The number of 
drug changes related to a recommendation in the medication review was 
also higher (1.3 vs. 0.2). The present study is an in-depth analysis into the 
type of recommendations for patients who received a medication review. 
Our first objective is to examine which drug groups are associated with 
recommendations resulting in drug changes. Our second objective is 




Cross-sectional analysis within the intervention arm of a pragmatic 
randomised controlled study in  a primary setting.
Patients
Patients were recruited from six Dutch community pharmacies. Patients 
were eligible if they were home-dwelling, aged 65 years and over 
and used five or more different drugs of which at least one had to be 
dispensed in an automated dispensing system. 
Intervention
Patients were randomly allocated to receive a medication review at start 
of the study (intervention group) or after six months (waiting-list group). 
Main outcome measures
The primary outcome measures were:  
1. the number of recommendations resulting in drug changes associated 
with drug groups and prescription indicator tools in the intervention 
group; 
2. the number of recommendations not resulting in drug changes 
associated with drug groups and prescription indicator tools in the 
intervention group .  
Results
Fifty-five patients in the intervention group received 246 
recommendations leading to a drug change (4,5 per patient). Seventy-two 
recommendations resulted in drug changes (33%).  
The three drug groups with the most recommendations resulting  in 
drug changes were agents acting at the renin-angiotensin system, other 
nervous system drugs and psychoanaleptics (see Table 1),
Drug groups with the most recommendations not resulting in drug 
changes were analgesics, psycholeptics and drugs for acid related 
disorders (see Table 2).  
The three prescription indicator tools resulting in most drug changes 
were ‘too low dose of lipid lowering drug’ , ‘ineffective drug for urinary 
incontinence’ and ‘aspirin without gastroprotection in patients aged > 70 
years’ (see Table 3).  
The three indicator tools not resulting in drug changes were ‘ischemic 
heart disease without lipid lowering drug’, ‘too high dosage of a 
benzodiazepine’ and ‘diabetes without lipid lowering drug’ (see Table 4).   
Table 1: Top 5 drug groups with the highest percent of recommendations 
resulting in drug changes








Agents acting on the Renin-Angiotensin System 
(C09)
3 5 60%
Other nervous system drugs (N07) 3 5 60%
Psychoanaleptics (N06) 5 9 56%
Beta blocking agents (C07) 7 14 50%
Drugs for obstructive airway diseases (R03) 6 15 40 %
Table 2: Top 5 drug groups with the lowest percent of recommendations 
resulting in drug changes








Analgesics (N02) 0 5 0%
Psycholeptics (N05) 1 18 6%
Drugs for acid related disorders (A02) 1 14 7%
Calcium channel blockers (C08) 1 10 10%
Drugs used in diabetes (A10)  4 25 16%
Table 3: Top 5 prescription indicator tools with the highest percent of 
recommendations resulting in drug changes






resulting in drug 
change
Too low dose of lipid lowering drug 2 2 100%
Ineffective drug for urinary incontinence 2 3 67%
Aspirin without gastroprotection 8 13 62%
Use of ineffective drugs for dizziness 3 5 60%
Inhalation type not suitable 2 4 50%
Table 4: Top 5 prescription indicator tools with the lowest percent of 
recommendations resulting in drug changes








Ischemic heart disease without lipid lowering drug’ 0 14 0%
Too high dosage of benzodiazepine 0 9 0%
Diabetes without lipid lowering drug 0 7 0%
Calcium channel blocker not effective for indication 0 7 0%
Use of opioids without laxative 0 6 0%
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Conclusion
This study shows a wide range in uptake of recommendations during 
a medication review. Additional research is needed to identify 
reasons why specific recommendations are (not) acted upon. 
